Advancements in Obesity Management (AOM)
Published: 20 June 2024
-
Views:
2952
-
Likes:
7
-
Views:
2952
-
Likes:
7
-
1h 4m 31s
-
1h 1mPart 1 Session 1: Obesity as a Disease, Diagnosis and Cardiovascular Disease Risk Naveed Sattar, Harold Bays, Mikhail Kosiborod, Ozden Gokdemir
Overview
The on-demand version of Advancements in Obesity Management (AOM) 2024 explores the intricate links between obesity and cardiovascular disease, providing key insights in evolving diagnostic and treatment strategies.
This event, led by Course Directors Dr Harold Bays (Louisville Metabolic and Atherosclerosis Research Centre, US) and Prof Naveed Sattar (University of Glasgow, UK) brings together a distinguished group of global faculty members who are renowned experts in the field of obesity and cardiovascular disease.
Split into four sessions, the faculty delve into the complexities of obesity and its multifaceted intricacies, spanning medical, surgical, nutritional, psychological and social dimensions for clinicians treating patients with obesity.
The live version of Advancements in Obesity Management was CME-accredited. This on-demand version is not.
Key Learning Objectives
- To understand the complex and multifactorial relationship between obesity and CV disease, including the biological, behavioural and environmental factors that contribute to this relationship
- To understand the impacts of obesity across the CV disease spectrum
- Apply current treatment methodologies to reduce the impact of obesity on CV disease utilising the multidisciplinary team
Target Audience
- Cardiologists
- Primary Care Physicians
- Endocrinologists
- Diabetologists
- Obesity Specialists
More from this programme
Part 1
Session 1: Obesity as a Disease, Diagnosis and Cardiovascular Disease Risk
The panel introduce a patient living with obesity, including current diagnosis and cardiovascular complications of the disease. Furthermore, the emerging data leading to a revolution in the treatment of obesity is discussed.
Part 2
Session 2: Rapid Fire Sessions - Challenges of Treating Specific CV Disease in Patients With Obesity
In the second session, the panel delve into treatment of specific CV diseases in patients living with obesity. Key co-morbidities discussed include diabetes, hypertension, dyslipidemia and thrombosis.
Part 3
Session 3: Healthful Nutrition, Physical Activity, Behaviour Modification and MDT
In this third session, the panel explore the biological, environmental, psychological and social factors contributing to obesity.
Part 4
Session 4: Medical and Procedural Options and the Referral Pathways
In the final session, the panel discuss practical considerations in utilising new pharmacological therapies for treating obesity and cover the extensive development pipeline. The current understanding of clinical outcome data and patient referral criteria are also discussed for surgical approaches.
Faculty Biographies
Naveed Sattar
Professor of Metabolic Medicine
Prof Naveed Sattar is a distinguished Professor of Metabolic Medicine at the renowned Institute of Cardiovascular and Medical Sciences, University of Glasgow. With over two decades of dedicated research and clinical experience, Prof Naveed Sattar has emerged as a leading figure in the field of metabolic medicine and cardiovascular health.
Prof Naveed Sattar's research delves into the origins, evaluation, and treatment of diabetes, obesity, and cardiovascular conditions. Collaborating with various colleagues over the past two decades, he has authored numerous impactful papers, notably with the Emerging Risk Factor Consortium and diabetes registries in Scotland and Sweden. Prof Naveed Sattar has contributed to several lifestyle-focused trials, such as DIRECT, EUROFIT, and UPBEAT, producing mechanistic insights alongside.
Linda Mellbin
Associate Professor of Cardiology
Linda Mellbin is Associate Professor of Cardiology and Head of the Coronary Artery Disease Patient Area at Karolinska University Hospital in Stockholm, Sweden.
Her research focus is on the field of diabetes and cardiovascular diseases at Karolinska Institutet.
Associate Professor Mellbin has authored several original papers, review articles and book chapters she was project leader for the EAPC (European Association of Preventive Cardiology) Educational Programme on Diabetes and Cardiovascular Disease and she was a member of the European Society of Cardiology Task Force updating the 2013 and 2019 guidelines on diabetes, pre-diabetes and cardiovascular diseases.
Neha Pagidipati
Assistant Professor of Medicine
Neha J Pagidipati is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is currently an NIH K12 scholar in Implementation and Dissemination Science.
Dr Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which focuses on behavior change and risk factor management in patients with high risk of cardiovascular and metabolic diseases such as diabetes and obesity.
Dr Pagidipati’s research grants include the COORDINATE-Diabetes Trial, to improve the quality of care for patients with diabetes and cardiovascular disease across the US, and QuBBD: Deep Poisson Methods for Biomedical Time-to-Event and Longitudinal Data.
In addition, she is leading a large study within the Duke Health System to study heterogeneity within cardiovascular disease risk and…
Vanita Aroda
Director of Diabetes Clinical Research
Vanita Aroda is the Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston, and Associate Professor of Medicine at Harvard Medical School in Boston, US.
Comments